基于专家的合作分析,分析了西班牙瘤学中的生物标志物测试实施情况和前景

相关实验视频

Updated: Jul 5, 2025

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.0K

Jorge Mestre-Ferrándiz1, Blanca Franch Camino2, Álvaro Hidalgo3

  • 1Universidad Carlos III, Madrid, Spain.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
|January 11, 2024
PubMed
概括

西班牙缺乏精准医学和生物标志物使用的国家战略,阻碍了其潜力. 拟议的路线图旨在指导公平的实施,并在全国范围内优化生物标志物确定.

关键词:
生物标志物 生物标志物政策路线图 政策路线图精准医学是一门精准的医学.西班牙西班牙西班牙西班牙西班牙在瘤学瘤学.

更多相关视频

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking07:34

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

690
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications05:26

A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications

Published on: September 16, 2022

4.0K

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353